Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
03. May 2026
Search
medline.ch
Oncology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 96556
Articles 1 - 20 / 1931103
Prostate cancer detection in routine clinical practice: a large cohort study in Japan.
Sci Rep
Wada A, Okinaka Y, Nagasawa M, Yoshida T, Ishitoya S, Osafune T, Kim CJ, Ushijima S, Murai R, Narita M, Nishikawa Z, Soga H, Ushida H, Sakano Y, Naya Y, Harada Y, Sano T, Tsuru T, Kobayashi K, Yamanaka K, Yoshida T, Kageyama S.
PMID: 42069962 [PubMed - as supplied by publisher]
Association between bedroom nighttime light pollution and risk of hepatic encephalopathy in hepatocellular carcinoma patients: a prospective cohort study.
Sci Rep
Li S, Zhang S, Li S, Meng T, Feng H.
PMID: 42069906 [PubMed - as supplied by publisher]
Complementary fluorescence and photoacoustic imaging of tozuleristide in muscle tissue in vitro- toward optically-guided solid tumor surgery: feasibility studies.
Sci Rep
Shang R, Thompson M, Carson MD, Seibel EJ, O'Donnell M, Pelivanov I.
PMID: 42069900 [PubMed - as supplied by publisher]
Economic evaluation of artificial intelligence for cancer detection in the UK breast screening programme.
Br J Cancer
Hill H, Roadevin C.
PMID: 42069897 [PubMed - as supplied by publisher]
Real-world chemotherapy use and survival outcomes in postmenopausal HR+/HER2-breast cancer with low genomic risk (RS ≤ 25): a multicenter cohort study from China.
Sci Rep
Hong C, Wang D, Chen Y, Lin S, Huang Y, Li L, Chen D, Lian W.
PMID: 42069896 [PubMed - as supplied by publisher]
Follow-up effects of exercise-based interventions on physical performance in cancer survivors: a systematic review and meta-analysis.
J Cancer Surviv
Brooks AM, Cunningham B, Siedler MR, Burkart S, Sarzynski MA, Parker NH, Fairman CM.
PMID: 42069881 [PubMed - as supplied by publisher]
Fifteen-year trends in cancer incidence and mortality among older adults aged 65 years and older in Martinique, a Caribbean population-based registry study, 2008-2022.
Sci Rep
Puello A, Beaubrun-Renard M, Macni J, Ulric-Gervaise S, Boullard M, Vestris M, Pierre-Louis A, George S, Dramé M, Joachim C.
PMID: 42069859 [PubMed - as supplied by publisher]
Multimodal modeling based on DNA methylation analysis in bronchoalveolar lavage fluid for early lung cancer detection.
Sci Rep
Liu J, You C, Bai L, Lv Y, Zeng W, Wang B, Zhang W, Huang Z, Ye D, Guo Y, Wang P, Zhou P, You H, Wu T, Wang C, Qing B, Xu Z.
PMID: 42069810 [PubMed - as supplied by publisher]
Doublet versus triplet therapy in Indian patients with locally advanced & metastatic gall bladder cancer: a randomised trial.
Sci Rep
Khatri C, Das PK, Rattan R, Patowary J.
PMID: 42069801 [PubMed - as supplied by publisher]
Cardiotoxicity of monoclonal antibody-based therapies in breast cancer: a contemporary narrative review.
Cardiooncology
Santos Nussbaum ACA, Antonini M, Mattar A, Bacal F, Monte Real J.
PMID: 42069784 [PubMed - as supplied by publisher]
Fungi and colorectal cancer: from dysregulation to clinical translation.
Gut Pathog
Yinhang W, Shuwen H, Jing Z, Min F.
PMID: 42069629 [PubMed - as supplied by publisher]
Is surgery necessary for mismatch repair-deficient/microsatellite instability-high colorectal cancer patients with a clinical complete response after neoadjuvant immunotherapy? A retrospective cohort study with literature context.
World J Surg Oncol
Zuo H, Huang J, Peng S, Wei J, Luo Y, Qin S, Zou X, Rong J, Lin Y, Lai H, Mo X.
PMID: 42069618 [PubMed - as supplied by publisher]
Fenofibrate as an anti-cancer treatment: an in vitro study on glioblastoma cells at various oxygen levels and on normal astrocytes.
Cancer Cell Int
Chokry Y, Groo AC, Corvaisier S, Ben Hadj Hassen O, Blanchard I, Valable S, Malzert-Fréon A.
PMID: 42069577 [PubMed - as supplied by publisher]
Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 - PRODIGE 107 - FFCD 2306 - COLOSOTO trial.
Dig Liver Dis
Grancher A, Landi M, Ballhausen A, Vidal Tocino R, Alig A, Taravella A, Le Malicot K, Soularue E, Gallois C, Guarssifi M, Pelkowski M, Beltran M, Kochen L, Delliponti L, Taïeb J, Sastre J, Modest DP, Cremolini C, Mazard T, Tougeron D.
PMID: 42069451 [PubMed - as supplied by publisher]
POST-CT-GUIDED BIOPSY PNEUMOTHORAX, ACCORDING TO THE COAXIAL TECHNIQUE WITH AN 18-GAUGE NEEDLE: EPIDEMIOLOGICAL, DIAGNOSTIC AND THERAPEUTIC ASPECTS.
Georgian Med News
Boukat A, Hamoummi M, Sarboute Y, Mohamed B, Emilie A, Meryem E, Kabiri E.
PMID: 42069437 [PubMed - indexed for MEDLINE]
Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial.
Lancet Haematol
Nicolini FE, Etienne G, Huguet F, Charbonnier A, Roth-Guépin G, Escoffre-Barbe M, Dubruille V, Johnson-Ansah H, Rousselot P, Legros L, Parry A, Roy L, Coiteux V, Lenain P, Ianotto JC, Doublet C, Orvain C, Simonet-Boissard M, Chrétien ML, Penot A, Meunier M, Amé S, Hermet E, Quittet P, Lapusan S, Schwiertz V, Cayuela JM, Mauté C, Réa D, Morisset S, Mahon FX, Dulucq S.
PMID: 42069411 [PubMed - indexed for MEDLINE]
Risks and benefits for patients with relapsed or refractory diffuse large B-cell lymphoma in early-phase clinical trials: a systematic review and meta-analysis.
Lancet Haematol
Spanjaart AM, Bakker M, de Vries R, Hutten BA, van Nieuwenhuijzen N, Minnema MC, Kuipers MT, Kersten MJ.
PMID: 42069410 [PubMed - indexed for MEDLINE]
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial.
Lancet Haematol
Palomba ML, Patel MR, Eyre TA, Jurczak W, Lewis D, Gastinne T, Ma S, Cohen JB, Patel K, Brown JR, Scarfò L, Munir T, Lech-Maranda E, Hoffmann MS, Ujjani CS, Fakhri B, Wang ML, Izutsu K, Nagai H, Tam CS, Rhodes JM, Vose J, McKinney M, Gerson JN, Barve MA, Kuss B, Koh Y, Barrett A, Treon SP, Castillo JJ, Seymour JF, Ruppert AS, McNeely SC, Walgren RA, Tsai DE, Bao K, Nair B, Woyach J, Cheah CY.
PMID: 42069409 [PubMed - indexed for MEDLINE]
Very early [(18)F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trial.
Lancet Haematol
Hutchings M, Diepstra A, Sureda Balari A, Carvalho S, Vranovsky A, Noordzij W, Loft A, Arens A, Teesink S, Visser L, Stevens W, Aleman BMP, Woei-A-Jin FJSH, Viguria M, Saevels K, Te Boome L, Tonino S, Meijnders P, Domingo Domènech E, Hasselbalch Riley C, Musekera L, Nuyens S, Mallien C, Sents W, Bührer E, Fortpied C, Plattel WJ.
PMID: 42069408 [PubMed - indexed for MEDLINE]
Performance of Magnetic Resonance Imaging in the Staging of Rectal Polyps Undergoing Endoscopic Resection: A US Academic Cancer Center Experience.
Gastrointest Endosc
Ge PS, Raju GS, Terrazas Morales VG, Liaw GK, Brown JJ, Trueba MG.
PMID: 42069262 [PubMed - as supplied by publisher]
Articles 1 - 20 / 1931103
Page 1 of 96556
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy